News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,716 Results
Type
Article (77923)
Company Profile (718)
Press Release (775043)
Multimedia
Podcasts (221)
Webinars (35)
Section
Business (228779)
Career Advice (3808)
Deals (39424)
Drug Delivery (172)
Drug Development (89928)
Employer Resources (207)
FDA (18269)
Job Trends (17253)
News (390182)
Policy (39061)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3042)
Academic (2)
Accelerated approval (49)
Adcomms (39)
Allergies (185)
Alliances (56305)
ALS (224)
Alzheimer's disease (1932)
Antibody-drug conjugate (ADC) (498)
Approvals (18554)
Artificial intelligence (772)
Autoimmune disease (312)
Automation (58)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (447)
Bladder cancer (194)
Brain cancer (80)
Breast cancer (791)
Cancer (6140)
Cardiovascular disease (526)
Career advice (3274)
Career pathing (49)
CAR-T (363)
CDC (75)
Celiac Disease (3)
Cell therapy (997)
Cervical cancer (49)
Clinical research (77133)
Collaboration (2251)
Company closure (8)
Compensation (1430)
Complete response letters (102)
COVID-19 (3028)
CRISPR (119)
C-suite (1196)
Cystic fibrosis (164)
Data (8027)
Decentralized trials (3)
Denatured (83)
Depression (185)
Dermatology (87)
Diabetes (630)
Diagnostics (7502)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (370)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (302)
Earnings (99708)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (136617)
Executive appointments (1161)
FDA (22131)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1834)
Gene editing (261)
Generative AI (78)
Gene therapy (820)
GLP-1 (1244)
Government (5514)
Grass and pollen (8)
Guidances (413)
Healthcare (21078)
HIV (88)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (344)
Immuno-oncology (104)
Indications (190)
Infectious disease (3399)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (298)
Interviews (749)
IPO (17883)
IRA (61)
Job creations (4987)
Job search strategy (2636)
JPM (73)
Kidney cancer (21)
Labor market (111)
Layoffs (673)
Leadership (50)
Legal (9978)
Liver cancer (107)
Longevity (34)
Lung cancer (805)
Lymphoma (439)
Machine learning (62)
Management (66)
Manufacturing (1128)
MASH (205)
Medical device (15203)
Medtech (15328)
Mergers & acquisitions (22791)
Metabolic disorders (1687)
mRNA (248)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (469)
Neuropsychiatric disorders (125)
Neuroscience (3576)
Neurotech (1)
NextGen: Class of 2026 (7663)
Non-profit (5137)
Now hiring (78)
Obesity (821)
Opinion (367)
Ovarian cancer (227)
Pain (272)
Pancreatic cancer (312)
Parkinson's disease (385)
Partnered (37)
Patents (622)
Patient recruitment (701)
Peanut (67)
People (66576)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23859)
Phase 2 (33638)
Phase 3 (25327)
Pipeline (8792)
Policy (385)
Postmarket research (3286)
Preclinical (10571)
Press Release (72)
Prostate cancer (311)
Psychedelics (68)
Radiopharmaceuticals (350)
Rare diseases (1198)
Real estate (7224)
Recruiting (81)
Regulatory (29365)
Reports (77)
Research institute (2758)
Resumes & cover letters (593)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (313)
Series B (226)
Service/supplier (27)
Sickle cell disease (121)
Special edition (31)
Spinal muscular atrophy (187)
Sponsored (55)
Startups (4265)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (135)
Vaccines (1264)
Venture capital (123)
Weight loss (566)
Women's health (129)
Worklife (24)
Date
Today (194)
Last 7 days (975)
Last 30 days (3762)
Last 365 days (32744)
2026 (13017)
2025 (32656)
2024 (37904)
2023 (42563)
2022 (53927)
2021 (58719)
2020 (57663)
2019 (51314)
2018 (39093)
2017 (36854)
2016 (37794)
2015 (43818)
2014 (38554)
2013 (34693)
2012 (36540)
2011 (36592)
2010 (36129)
Location
Africa (1224)
Alabama (101)
Alaska (7)
Arizona (369)
Arkansas (16)
Asia (50474)
Australia (8674)
California (13725)
Canada (3834)
China (1446)
Colorado (594)
Connecticut (605)
Delaware (418)
Europe (115517)
Florida (2031)
Georgia (447)
Hawaii (4)
Idaho (68)
Illinois (1156)
India (96)
Indiana (637)
Iowa (25)
Japan (551)
Kansas (139)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1677)
Massachusetts (10028)
Michigan (403)
Minnesota (765)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3655)
New Mexico (34)
New York (3595)
North Carolina (1854)
North Dakota (11)
Northern California (6783)
Ohio (427)
Oklahoma (26)
Oregon (53)
Pennsylvania (2724)
Puerto Rico (30)
Rhode Island (53)
South America (1587)
South Carolina (87)
South Dakota (2)
Southern California (5372)
Tennessee (216)
Texas (2203)
United States (49091)
Utah (411)
Vermont (1)
Virginia (352)
Washington D.C. (88)
Washington State (1128)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
853,716 Results for "rentschler biotechnologie gmbh and co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board
February 11, 2026
·
5 min read
Press Releases
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
January 21, 2026
·
5 min read
Press Releases
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
January 8, 2026
·
6 min read
Press Releases
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
December 2, 2025
·
5 min read
Press Releases
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
January 22, 2026
·
3 min read
Press Releases
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
April 14, 2026
·
1 min read
Press Releases
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
October 24, 2025
·
4 min read
Press Releases
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
April 29, 2026
·
5 min read
Mergers & acquisitions
Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities
Gilead Sciences has inked three deals this year so far totaling $14.77 billion, a marked escalation of the company’s usual M&A pace. Executives detailed the rationale for buying Arcellx, Ouro Medicine and Tubulis GmbH and whether they are interested in further deals.
April 8, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026
Over 300 million patients are infected with HCV, HBV, HDV, and their co-infections. MDL-001 is the first oral small molecule to demonstrate potent, direct-acting antiviral activity across all three viruses and their co-infections.
February 18, 2026
·
1 min read
1 of 85,372
Next
